Trademark: 97229959
Status Date
Monday, March 11, 2024
Filing Date
Thursday, January 20, 2022
Published for Opposition
Tuesday, August 2, 2022
5 Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Mar 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 11, 2024
Sou Extension 3 Granted
Mar 11, 2024
Sou Extension 3 Filed
Mar 11, 2024
Sou Teas Extension Received
Sep 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 18, 2023
Sou Extension 2 Granted
Sep 18, 2023
Sou Extension 2 Filed
Sep 18, 2023
Sou Teas Extension Received
Mar 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 14, 2023
Sou Extension 1 Granted
Mar 14, 2023
Sou Extension 1 Filed
Mar 14, 2023
Sou Teas Extension Received
Sep 27, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2022
Published For Opposition
Jul 13, 2022
Notification Of Notice Of Publication E-Mailed
Jun 29, 2022
Approved For Pub - Principal Register
Jun 27, 2022
Teas/Email Correspondence Entered
Jun 27, 2022
Correspondence Received In Law Office
Jun 27, 2022
Teas Response To Office Action Received
Mar 2, 2022
Notification Of Non-Final Action E-Mailed
Mar 2, 2022
Non-Final Action E-Mailed
Mar 2, 2022
Non-Final Action Written
Mar 2, 2022
Assigned To Examiner
Jan 25, 2022
New Application Office Supplied Data Entered
Jan 24, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
